Randomized controlled trial of twice-a-day administration of natural interferon β for chronic hepatitis C
スポンサーリンク
概要
- 論文の詳細を見る
- 2000-11-01
著者
-
Kakumu S
Division Of Gastroenterology Department Of Internal Medicine Aichi Medical University School Of Medi
-
KAKUMU Shinichi
Department of Internal Medicine, GI Division, Aichi Medical University School of Medicine
-
Kuwahara Seiichiro
久留米大学 医学部第2内科消化器内科部門
-
Kiso Shinichi
Second Department Of Internal Medicine Osaka University Medical School
-
Kubota Shinji
大阪大学 医学系研究科消化器内科学
-
ISHIKAWA Tetsuya
Cancer Immunotherapy Center, Nagoya Kyoritsu Hospital
-
YANO MOTOYOSHI
Third Department of Internal Medicine, Nagoya University School of Medicine
-
YOSHIOKA KENTARO
Third Department of Internal Medicine, Nagoya University School of Medicine
-
ARAO MOTOHIRO
Department of Internal Medicine, Inazawa Municipal Hospital
-
MURASE KENICHI
Department of Internal Medicine, Chubu Rosai Hospital
-
KUSAKABE ATSUHIKO
Department of Internal Medicine, Nagoya First Red Cross Hospital
-
SAMESHIMA YOICHI
Department of Internal Medicine, Nagoya First Red Cross Hospital
-
Yoshioka K
Nagoya Univ. School Of Medicine
-
Yano Motoyoshi
愛知学院大学 薬学部薬物治療学
-
Yano Motoyoshi
Department Of Gastroenterology Yokkaichi City Hospital
-
Yano Motoyoshi
Third Department Of Internal Medicine Nagoya University School Of Medicine
-
Yano Motoyoshi
The Third Department Of Internal Medicine Nagoya University
-
Yano Motoyoshi
The Third Department Of Iinternal Medicine Nagoya University School Of Medicine
-
Sumida Yoshio
Department Of Gastroenterology And Hepatology Nara City Hospital
-
Yamanouchi Kunio
稲沢市民病院
-
Arao M
Inazawa Municipal Hospital Inazawa Jpn
-
Arao Motohiro
Department Of Internal Medicine Inazawa Municipal Hospital
-
Murase Kenichi
Department Of Internal Medicine Chubu Rosai Hospital
-
Kakumu Shinichi
Division Of Gastroenterology Department Of Internal Medicine Aichi Medical University
-
Ishikawa Tetsuya
愛知医科大学 医学部消化器内科
-
Ishikawa Tetsuya
Cancer Immunotherapy Center Nagoya Kyoritsu Hospital
-
ISHIKAWA Tetsuya
First Department of Internal Medicine, Research Center for Infectious Disease, Aichi Medical Univers
-
HIROFUJI Hideo
Department of Internal Medicine, Yokkaichi Municipal Hospital
-
KURIKI Junsuke
Department of Internal Medicine, Gamagori Municipal Hospital
-
KUROKAWA Susumu
Department of Internal Medicine, Chubu Rosai Hospital
-
Kakumu Shinichi
Department Of Signal Transduction Cancer Research Institute Kanazawa University
-
Kurokawa Susumu
Department Of Internal Medicine Chubu Rosai Hospital
-
Sumida Yoshio
Center For Digestive And Liver Diseases Nara City Hospital
-
Kakiuchi Yoshimi
Department Of Hepato-biliary-pancreas Fujita Health Science
-
Kuriki Junsuke
Department Of Internal Medicine Gamagori Municipal Hospital
-
Kusakabe Atsuhiko
Department Of Internal Medicine Nagoya First Red Cross Hospital
-
Kusakabe Atsuhiko
Department Of Gastroenterology Japanese Red Cross Nagoya First Hospital
-
Hirofuji Hideo
Department Of Internal Medicine Yokkaichi Municipal Hospital
-
Ishikawa Tetsuya
Department Of Internal Medicine Aichi Medical University School Of Medicine
-
Kakumu Sinichi
Department Of Gastroenterology Aichi Medical University School Of Medicine
-
Sameshima Yoichi
Department Of Internal Medicine Nagoya First Red Cross Hospital
-
Suzuki Y
Department Of Hygiene The University Of Tokushima School Of Medicine
-
Yoshioka Kentaro
Third Department Of Internal Medicine Nagoya University School Of Medicine
-
Yoshioka Kentaro
Third Department Internal Medicine Nagoya University School Of Medicine
-
Kakumu Shinichi
Department Of Gastroenterology Aichi Medical University School Of Medicine
-
Katano Yoshiaki
Second Department Of Internal Medicine Nagoya University School Of Medicine
-
Suzuki Yasuaki
Division Of Gastroenterology And Hematology/oncology Department Of Medicine Asahikawa Medical Colleg
-
Ishikawa Tetsuya
First Department Of Internal Medicine And Research Center For Infections Disease Aichi Medical Unive
-
Ishikawa Tetsuya
Department Of Medical Technology Nagoya University School Of Health Sciences
-
Suzuki Yasuaki
Center For Digestive And Liver Diseases Nara City Hospital
関連論文
- PE-152 Adiponectin Deficiency Suppresses ABCA1 Expression and ApoA-I Synthesis in the Liver(Atherosclerosis, basic(04)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-092 Exacerbation of Albuminuria and Renal Fibrosis in Subtotal Renal Ablation Model of Adiponectin-Knockout Mice(Renal Dysfunction and Cardiovascular Disease(H),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation S
- Reciprocal Relationship between Adiponectin and C-Reactive Protein
- Adiponectin : A Key Molecule of the Metabolic Syndrome
- Contribution of Adiponectin Gene Mutation to Coronary Artery Disease
- Association of Adiponectin Mutation with the Metabolic Syndrome
- Adiponectin Dysregulation as a Common Cause of Insulin Resistance and Atherosclerosis
- Role of Adiponectin in Preventing Vascular Stenosis : The Missing Link of Adipo-Vascular Axis
- PE-151 Adiponectin Promotes Cholesterol Efflux from Human Macrophages throuth ABCA1-dependent Pathway(Atherosclerosis, basic(04)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Novel ELISA for Apo B-48 Revealed Chylomfcron Remnants (CR) Are Accumulated in the Plasma of Diabetic Patients despite Normolipidemia
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Reply to Letter Regarding Article, "Clinical Significance of High-Molecular Weight Form of Adiponection in Male Patients With Coronary Artery Disease"(Author's Reply)
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis : A prospective, multicenter study
- Acute Pancreatitis and Hyperchylomicronemia
- Chronic Inflammatory Demyelinating Polyneuropathy Accompanied by Hepatocellular Carcinoma
- High-performance liquid chromatographic assay for farnesyl-protein transferase activity with dabsylated peptide
- A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Clinical Significance of High-Molecular Weight Form of Adiponectin in Male Patients With Coronary Artery Disease
- Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
- Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
- The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
- Interferon therapy for aged patients with chronic hepatitis C : improved survival in patients exhibiting a biochemical response
- Efficacy of combination therapy of interferon-α with ursodeoxycholic acid in chronic hepatitis C: A randomized controlled clinical trial
- Inflammatory cytokines modulate chemokine production patterns of HepG2 cells toward initially inclined direction
- Intrahepatic gene expression profiles in chronic hepatitis B and autoimmune liver disease
- Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4+CD25+ T cells in patients with autoimmune hepatitis
- Changes in intrahepatic gene expression profiles from chronic hepatitis to hepatocellular carcinoma in patients with hepatitis C virus infection
- Expression of Rab5a in hepatocellular carcinoma : Possible involvement in epidermal growth factor signaling
- Development of complementary expression patterns of E- and N-cadherin in the mouse liver
- Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection
- The SHAP-hyaluronan complex in serum from patients with chronic liver diseases caused by hepatitis virus infection
- Plasma amino acid profiles applied for diagnosis of advanced liver fibrosis in patients with chronic hepatitis C infection
- Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
- Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
- A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
- Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus
- Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum γ-glutamyltranspeptidase levels
- Changes in serum hepatic fibrosis markers in biochemical responders to interferon therapy for chronic hepatitis C
- Suppression of Human Pancreatic Cancer Growth in BALB/c Nude Mice by Manumycin, a Farnesyl:protein Transferase Inhibitor
- PJ-679 Clinical Significance of High Molecular Weight Form of Adiponectin in Male Patients with Coronary Artery Disease(Diabetes / Obesity / Metabolic syndrome(14)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation
- Adiponectin as a Biomarker of the Metabolic Syndrome
- OE-031 The Decrease of Plasma Adiponectin Predicts Future Adverse Events in Patients with Acute Myocardial Infarction(Acute Myocardial Infarction, Clinical (Pathophysiology) 1 (IHD) : OE4)(Oral Presentation (English))
- Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus
- Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
- Influence of a Novel Adipocyte-Derived Protein, Adiponectin on Fibrinolysis and Inflammation in Stable Effort Angina
- The Levels of Adipocyte-Derived Plasma Protein, Adiponectin, Have a Close Relation with Atherosis Rather Than Sclerosis
- Expression of Fas/Fas ligand (FasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC)
- OE-311 Adiponectin predicts myocardial salvage following successful reperfusion in patients with acute myocardial infarction(Myocardial ischemia/reperfusion, basic/clinical(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japa
- PJ-636 Adiponectin : a Predictor of Cardiac Remodeling in Humans with Chronic Systolic Heart Failure(Heart failure, clinical-17, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-431 Role of Adiponectin in the Development of Chronic Heart Failure(Heart failure, basic-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-071 Accumulation and Expression of Adiponectin in Damaged Cardiac Tissue Following Ischemia-reperfusion(Myocardial ischemia/reperfusion, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells
- Mutation at codon 130 in hepatitis B virus (HBV) core region increases markedly during acute exacerbation of hepatitis in chronic HBV carriers
- Randomized controlled trial of twice-a-day administration of natural interferon β for chronic hepatitis C
- Interleukin 2 and γ/δ T-cell receptors in peripheral blood of patients with chronic hepatitis C virus infection
- Role of Vα14^+ NKT cells in the development of Hepatitis B virus-specific CTL : activation of Vα14^+ NKT cells promotes the breakage of CTL tolerance
- Immunopathogenesis of hepatic fibrosis in chronic liver injur induced by repeatedly administered concanavalin A
- Association of Hypo-Adiponectinemia with Coronary Artery Disease in Women
- A Novel Plasma Protein Abundantly Expressed in Visceral Fat, Visfatin, Associated with Coronary Artery Disease
- Hypo-adiponectinemia as an Independent Coronary Risk Factor in Osaka CAD Study Group
- Lower Plasma Adiponectin Concentration Increases Risk for Hypertension
- Hepatitis B virus genotype G is an extremely rare genotype in Japan
- Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat : possible role in amelioration of insulin resistance and hepatic steatosis
- Separate analysis of asialoglycoprotein receptors in the right and left hepatic lobes using ^Tc-GSA SPECT in patients with acute hepatic damage
- Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of the transplanted cells in the injured liver
- Successful percutaneous radiofrequency ablation of adrenal metastasis from hepatocellular carcinoma
- Reduction of serum ghrelin concentration during interferon-α therapy in patients with chronic hepatitis C
- Expression of Notch signalling markers in bone marrow cells that differentiate into a liver cell lineage in a rat transplant model
- Transmission of hepatitis C virus quasispecies between human adults
- Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma
- The Protective Role of Glutathione Peroxidase in Ppoptosis Induced by Reactive Oxygen Species^1
- Factors Responsible for Nocturnal Intragastric pH Elevation in Helicobacter pylori-Positive Gastric Ulcer Patients
- PE-227 Impact of Hypoadiponectinemia on Altered Cardiac Fatty Acid Metabolism in Obesity(Nuclear cardiology(04)(I),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-255 Association of Serum Adiponectin and Matrix Metalloproteinases-9 Levels with Left Ventricular Remodeling after Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-1, The 71st Annual Scientific Meeting of the Japanese
- Adiponectin deficiency enhanced the severity of cerulein-induced chronic pancreatitis in mice
- Adiponectin Acts as a PDGF-BB Binding Protein, and Regulates Growth Factor-Induced Post-Receptor Signal in Vascular Smooth Muscle Cell
- The Metabolic Syndrome in Japanese and the Role of Adipocytokines
- Marked Differences In Visceral Fat Accumulation-Related Cardiovascular Risk Factors between Young and Elderly Patientswith Coronary Artery Disease
- Adiponectin is a Predictive Visceral Fat Accumulation-Related Cardiovascular Risk Factor
- A Plasma Protein Abundantly Expressed in Visceral Fat, Visfatin Modulates Inflammatory Response in Human Monocyte-derived Macrophages
- A Patient with Chronic Hepatitis C Who Obtained Sustained Response by Retreatment of Interferon after Decrease of Viral Load and Mutation in Interferon Sensitivity Determining Region
- The Role of Intrahepatic γδ-T Cells for Liver Injury Induced by Salmonella Infection in Mouse
- Adipocyte-Derived Plasma Protein, Adiponectin, Prevents Atherosclerosis in Apolipoprotein E-Deficient Mice
- Real-time detection system for quantitation of hepatitis C virus RNA : a comparison with the other three methods
- 3. Role of Adipocytokines on the Pathogenesis of Atherosclerosis in Visceral Obesity
- A Plasma Protein Abundantly Expressed in Visceral Fat, Visfatin, Increases Endothelial MCP-1 Expression and Contributes to Coronary Artery Disease
- The Variation of Plasma Levels of a Novel, Adipocyte-derived Protein, Adiponectin, in Patients with Acute Myocardial Infarction
- Autoantibody against a 78 kDa membrane protein of HepG2 cell in the sera of patients with alcoholic liver diseases
- Expression of the RNA-binding protein Musashi1 in adult liver stem-like cells
- Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
- ^Tc-GSA SPECT analysis was clinically useful to evaluate the effect of interferon in a patient with interferon non-responsive chronic hepatitis C